comparemela.com

Latest Breaking News On - Ajay kirtane - Page 15 : comparemela.com

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

UNIVERSAL missed its primary endpoint, but one investigator likened its use to wearing a seatbelt that’s already in the car.

New yorkUnited statesUniversity of pennsylvaniaAjay kirtaneSanjits jollyMauriciog cohenRoxana mehranAjay giriAlexanderc fanaroffMd university of miami hospitalMsc population health research institutePresbyterian columbia university irving medical centerPopulation health research instituteMiami hospitalColumbia university irving medical centerIcahn school

SCAAR Registry Delves Into Left Main Revascularization Outcomes

The observational data raised red flags for many, including the fact that CABG survival curves appeared to separate so quickly.

New yorkUnited statesVastra gotalands lanRichard whitlockAjay kirtaneEric cohenElmir omerovicRoxana mehranFaisal bakaeenMd cardiovascular research foundationPhd sahlgrenska university hospitalMd mcmaster university population health research institutePresbyterian columbia university irving medical centerSwedish coronary angiographyAngioplasty registrySahlgrenska university hospital

SYMPLICITY HTN-3 s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Experts grappled with how to understand the positive findings given that the trial missed its primary endpoint at 6 months.

New yorkUnited statesSalt lake cityUniversity of utahNaomi fisherAjay kirtaneDeepak bhattSymplicity spyralAmerican college of cardiologyMd university of utah health sciences centerPresbyterian columbia university irving medical centerSymplicity flexNew england journalRecor medicalUtah health sciences centerAmerican college

ReCor ultrasound renal denervation trial meets primary endpoint

ReCor Medical announced that a trial for its Paradise ultrasound renal denervation (uRDN) treatment met its primary efficacy endpoint.

United statesAjay kirtaneMichel aziziAndrewm weissEuropean society of cardiologyRecor medicalCalifornia based recorEuropean society

RDN Powers Through Another Off-Med Trial, Clinical Benefits Still Untested

Plus, an apparent magnification of effect in SYMPLICITY HTN-3

New yorkUnited statesAjay kirtaneNaomi fisherNicole louFelix mahfoudSaarland university medical centerHarvard medical schoolPresbyterian columbia university irving medical centerCardiovascular research foundationTranscatheter cardiovascular therapeuticsCardiovascular researchColumbia university irving medical centerSymplicity flexMedpage today

vimarsana © 2020. All Rights Reserved.